Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
First Alert: Light snow through this evening - 2Instructions to Help a Friend or family member Determined to have Cellular breakdown in the lungs
- 3Thousands of Walgreens nasal spray bottles recalled. See which ones.
- 4Creative Tech Contraptions That Will Work on Your Life
- 5South Carolina's measles outbreak reaches 434 cases
- Zelensky sees new Russian attack threat from Belarus
- Young Muslims in Germany feel left out of Mideast debate, experts say
- 'Senseless violence' erupts at Christmas tree lighting; 4 injured
- PHOTO ESSAY: Summer camp for kids with autoimmune diseases
- Grasping the Basics of Business Land Regulation
- Norovirus is spreading earlier again this year, wastewater data shows
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Glen Powell will host 'Saturday Night Live' with Olivia Dean as musical guest: What to know ahead of their debut
- With Obamacare premium hikes, more people opting for no coverage or cheaper plans
